Cargando…

Prokaryotic and Eukaryotic Fecal Microbiota in Irritable Bowel Syndrome Patients and Healthy Individuals Colonized With Blastocystis

Blastocystis is the most frequently isolated protozoan from human stool. Its role in human health is still debated, and a high prevalence was reported in irritable bowel syndrome (IBS) subjects, suggesting a potential link with microbiota. In the present study, we aimed to investigate prokaryotic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nourrisson, Céline, Scanzi, Julien, Brunet, Julie, Delbac, Frédéric, Dapoigny, Michel, Poirier, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486285/ https://www.ncbi.nlm.nih.gov/pubmed/34603241 http://dx.doi.org/10.3389/fmicb.2021.713347

Ejemplares similares

Blastocystis Is Associated with Decrease of Fecal Microbiota Protective Bacteria: Comparative Analysis between Patients with Irritable Bowel Syndrome and Control Subjects
por: Nourrisson, Céline, et al.
Publicado: (2014)

New Insights into Blastocystis spp.: A Potential Link with Irritable Bowel Syndrome
por: Poirier, Philippe, et al.
Publicado: (2012)

Comparison of DNA Extraction Methods and Real-Time PCR Assays for the Detection of Blastocystis sp. in Stool Specimens
por: Nourrisson, Céline, et al.
Publicado: (2020)

Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats
por: Defaye, Manon, et al.
Publicado: (2020)

Efficient and reproducible experimental infections of rats with Blastocystis spp.
por: Defaye, Manon, et al.
Publicado: (2018)

Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2017)

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients
por: Nagel, Robyn, et al.
Publicado: (2016)

Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.
por: Olyaiee, Alireza, et al.
Publicado: (2022)

Prevalence and Risk Factors for Intestinal Protozoan Infections with Cryptosporidium, Giardia, Blastocystis and Dientamoeba among Schoolchildren in Tripoli, Lebanon
por: Osman, Marwan, et al.
Publicado: (2016)

Correction: Prevalence and Risk Factors for Intestinal Protozoan Infections with Cryptosporidium, Giardia, Blastocystis and Dientamoeba among Schoolchildren in Tripoli, Lebanon
por: Osman, Marwan, et al.
Publicado: (2016)

Eukaryotic and Prokaryotic Microbiota Interactions
por: Kodio, Aly, et al.
Publicado: (2020)

Draft genome sequence of the intestinal parasite Blastocystis subtype 4-isolate WR1
por: Wawrzyniak, Ivan, et al.
Publicado: (2015)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?
por: Salvador, Fernando, et al.
Publicado: (2021)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection
por: Boorom, Kenneth F, et al.
Publicado: (2008)

Molecular Epidemiology of Blastocystis sp. in Various Animal Groups from Two French Zoos and Evaluation of Potential Zoonotic Risk
por: Cian, Amandine, et al.
Publicado: (2017)

Microbiota characterization in Blastocystis-colonized and Blastocystis-free school-age children from Colombia
por: Castañeda, Sergio, et al.
Publicado: (2020)

Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp.
por: Chaparro-Olaya, Jacqueline, et al.
Publicado: (2022)

Lactobacillus gasseri LA806 Supplementation in Patients with Irritable Bowel Syndrome: A Multicenter Study
por: Ait Abdellah, Samira, et al.
Publicado: (2022)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Fecal Microbiota Signatures Are Not Consistently Related to Symptom Severity in Irritable Bowel Syndrome
por: Wang, Taojun, et al.
Publicado: (2022)

Blastocystis sp. in Irritable Bowel Syndrome (IBS) - Detection in Stool Aspirates during Colonoscopy
por: Ragavan, Nanthiney Devi, et al.
Publicado: (2015)

Additional Glance on the Role of Dientamoeba fragilis & Blastocystis hominis in Patients with Irritable Bowel Syndrome
por: IBRAHIM, Ayman Nabil, et al.
Publicado: (2018)

Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France
por: El Safadi, Dima, et al.
Publicado: (2016)

The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
por: Gobert, Alain P., et al.
Publicado: (2016)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Fecal microbiota transplantation for patients with irritable bowel syndrome: A meta-analysis protocol
por: Wen, Wenting, et al.
Publicado: (2018)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Blastocystis specific serum immunoglobulin in patients with irritable bowel syndrome (IBS) versus healthy controls
por: Nagel, Robyn, et al.
Publicado: (2015)

Molecular Characterization and Subtyping of Blastocystis Species in Irritable Bowel Syndrome Patients from North India
por: Das, Rojaleen, et al.
Publicado: (2016)

Blastocystis ST-1 is associated with Irritable Bowel Syndrome-diarrhoea (IBS-D) in Indonesian adolescences()
por: Kesuma, Yudianita, et al.
Publicado: (2019)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients
por: Terveer, Elisabeth M, et al.
Publicado: (2019)

Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients
por: Nagel, Robyn, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mkv5ol5ela5vha8pcvvd906oe5